MedEsthetics
FEBRUARY 19, 2024
The program provides skin therapists with the expertise and proficiency necessary to excel in their careers utilizing Circadia's portfolio of products.
Dermatology Times
FEBRUARY 19, 2024
From the February cover: Joseph Zabinski, PhD, MEM, and Stefan Weiss, MD, MBA, FAAD, share their expertise into AI’s capabilities in dermatology and specifically, rare diseases such as generalized pustular psoriasis.
The Dermatology Digest
FEBRUARY 19, 2024
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Certa Therapeutics’ investigational therapy FT011 for the treatment of systemic sclerosis. FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs. It targets a GPCR receptor, GPCR68, with an extensive body of data demonstrating promising efficacy in multiple models of fibrotic disease.
Dermatology Times
FEBRUARY 19, 2024
Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Hollywood Institute
FEBRUARY 19, 2024
The new year has introduced us to fresh and new nail art trends and styles. The best way to impress your salon clients is to stay updated on the latest nail designs. We have curated a selection of popular nail styles to equip you with the latest trends, enabling you to provide your clients with the most fashionable nail makeovers! Chrome Nails This year, chrome effect nails have already taken the spotlight.
Dermatology Times
FEBRUARY 19, 2024
Miller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
FEBRUARY 19, 2024
Joel Gelfand, MD, explained how body surface area on patients with psoriasis plays a pivotal role in cardiovascular outcomes.
Style Seat - Business Growth
FEBRUARY 19, 2024
Here are a few tips to help make tax season less scary. The post Helpful Tax Tips for Independent Stylists and Salon Owners appeared first on StyleSeat Pro Beauty Blog.
Dermatology Times
FEBRUARY 19, 2024
Almirall now possesses the rights to develop and commercialize NN-8828, particularly in immune inflammatory dermatological diseases.
Skin Inc
FEBRUARY 19, 2024
The program provides skin therapists with the expertise and proficiency necessary to excel in their careers utilizing Circadia's portfolio of products.
Dermatology Times
FEBRUARY 19, 2024
Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Beauty Launchpad
FEBRUARY 19, 2024
Each product will retail at $50, placing the tools at the more accessible ends of the category spectrum at Sephora.
Dermatology Times
FEBRUARY 19, 2024
Botox? Iontopherisis? Let us know what you most often recommend to your patients with severe palmar hyperhidrosis.
The Dermatology Digest
FEBRUARY 19, 2024
Several uremic toxins may cause itching in hemodialysis patients, new research suggests. Although its exact causes remain unclear, itching in hemodialysis patients has been associated with elevated levels of β 2 -microglobulin, calcium, phosphorus, or parathyroid hormone in the blood. Subsequently, improvements in hemodialysis therapy and pharmacological treatments have led to changes in the severity of itching and its associated factors in hemodialysis patients.
Dermatology Times
FEBRUARY 19, 2024
Lifileucel is a tumor-derived autologous T cell immunotherapy.
The Dermatology Digest
FEBRUARY 19, 2024
IFPA has released the Psoriatic Care Roadmap and Action Playbook for Asia. The new resources are guides featuring advocacy demands and practical strategies that aim to elevate psoriatic care across the continent. The roadmap addresses four crucial themes that emerged from the IFPA Forum Asia 2023, held in Singapore: 1. Access to Care for People with Psoriatic Disease 2.
The Dermatology Digest
FEBRUARY 19, 2024
Almirall S.A. has entered into an exclusive license agreement with Novo Nordisk for rights to the IL-21 blocking monoclonal antibody NN-8828. Under the agreement, Almirall obtains global rights to develop and commercialize this monoclonal antibody in certain fields, including immune inflammatory dermatological diseases. NN-8828 has the potential to block the activation of the downstream signaling pathways of IL-21 and inhibit the pathophysiological functions induced by this cytokine in severa
Expert insights. Personalized for you.
78 
Let's personalize your content